The present invention relates to compounds having the formula, wherein, Q is optionally substituted aryl or heteroaryl, R.sub.1 is hydrogen or C.sub.1-4alkyl, and R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are hydrogen or optional substituents as defined in the specification.

 
Web www.patentalert.com

< Conopeptides and methods of use

< RNA interference mediated inhibition of stromal cell-derived factor-1 (SDF-1) gene expression using short interfering nucleic acid (siNA)

> Granzyme b inhibitors

> Method for treating nervous system disorders and conditions
~ 00234